Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
603392
Kedudukan dalam Saham
#3680
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a biopharmaceutical... Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a biopharmaceutical firm that handles the entire process from research and development to the production, marketing, and distribution of diagnostic solutions for infectious diseases and various vaccines. The company operates extensively across China and in international markets. Its comprehensive product range offers diagnostic test kits for a multitude of infectious agents, including COVID-19, HIV, HTLV, Hepatitis, EV-71, and Tuberculosis. It also provides specific detection reagents for Hepatitis C and Syphilis. Beyond these, the portfolio includes advanced diagnostic tools such as automated immunoassays, ELISA kits, rapid diagnostic tests, and various chemiluminescence, clinical chemistry, and general immunodiagnostic reagents. Furthermore, Beijing Wantai is a developer and supplier of vaccines for Hepatitis E and human papillomavirus (HPV). The company serves a wide array of clients, including blood banks, hospitals and clinics, specialized reference laboratories, border inspection centers, blood-processing companies, and scientific research institutes. Established in 1991, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is headquartered in China's capital city, Beijing.
Harga Saham
$3.62
Modal Pasaran
$4.58B
Perubahan (1 hari)
-0.16%
Perubahan (1 tahun)
-53.12%
Negara
CN
Perdagangan Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392)
Kategori
Healthcare
Margin Operasi untuk Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392)
Margin Operasi pada October 2026 TTM: -22.69%
Menurut laporan kewangan dan harga saham terkini Beijing Wantai Biological Pharmacy Enterprise Co., Ltd., margin operasi semasa (TTM) ialah -22.69%. Pada akhir 2023, margin operasi syarikat ialah 25.43%.
Sejarah Margin Operasi untuk Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. dari 2013 hingga 2026
Margin Operasi pada akhir setiap tahun
| Tahun | Margin Operasi | Ubah |
|---|---|---|
| 2026 (TTM) | -22.69% | -642.82% |
| 2024 | 4.18% | -83.56% |
| 2023 | 25.43% | -49.17% |
| 2022 | 50.03% | 23.56% |
| 2021 | 40.49% | 22.96% |
| 2020 | 32.93% | 78.58% |
| 2019 | 18.44% | -37.32% |
| 2018 | 29.42% | 56.32% |
| 2017 | 18.82% | 20.87% |
| 2016 | 15.57% | -13.02% |
| 2015 | 17.90% | -7.40% |
| 2014 | 19.33% | 0.26% |
| 2013 | 19.28% | 0.00% |
Margin Operasi untuk syarikat serupa atau pesaing
| Syarikat | Margin Operasi | Perbezaan Margin Operasi | Negara |
|---|---|---|---|
| 38.59% | -101.70% |
US
|
|
| -149.01% | -93.43% |
US
|
|
| 25.57% | -101.13% |
AU
|
|
| 0.00% | - |
CH
|
|
| 28.81% | -101.27% |
NL
|
Apakah Margin Operasi sesebuah syarikat?
Margin Operasi ialah penunjuk utama untuk menilai keuntungan sesebuah syarikat. Margin Operasi yang lebih tinggi lazimnya lebih baik kerana menunjukkan bahawa syarikat mampu menjual produk atau perkhidmatannya dengan harga yang jauh lebih tinggi daripada kos pengeluarannya. Ia dikira dengan membahagikan keuntungan syarikat dengan hasilnya.